Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome

被引:15
|
作者
Choi, Yunsuk [1 ]
Hur, Eun-Hye [2 ]
Moon, Ju Hyun [2 ]
Goo, Bon-Kwan [2 ]
Choi, Dae Ro [3 ]
Lee, Je-Hwan [2 ]
机构
[1] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Hematol & Oncol, Ulsan, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[3] Hallym Univ, Chuncheon Sacred Heart Hosp, Dept Internal Med, Chunchon, South Korea
来源
KOREAN JOURNAL OF INTERNAL MEDICINE | 2019年 / 34卷 / 02期
关键词
Myelodysplastic syndromes; MIRN126; microRNA; human; hsa-146b-5p; MIRN155; MIRN200; HEMATOPOIETIC STEM-CELLS; SCORING SYSTEM; CANCER;
D O I
10.3904/kjim.2016.239
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Various alterations of microRNA (miRNA) expression have been reported in myelodysplastic syndrome (MDS). We aimed to investigate the unique patterns and prognostic significance of miRNA expression in Korean patients with MDS. Methods: Bone marrow mononuclear cells were collected from eight healthy controls and 26 patients with MDS, and miRNAs were isolated and assessed via quantitative real-time polymerase chain reaction for selected miRNAs, including miR-21, miR-124a, miR-126, miR-146b-5p, miR-155, miR-182, miR-200c, miR 342-5p, miR 708, and Let 7a. Results: MiR-124a, miR-155, miR-182, rniR-200c, miR-342-5p, and Let-7a were significantly underexpressed in patients with MDS, compared to healthy controls. MiR-21, miR-126, 146b-5p, and miR-155 transcript levels were significantly lower in international prognostic scoring system lower (low and intermediate-1) risk MDS than in higher (intermediate-2 and high) risk MDS. Higher expression levels of miR-126 and miR-155 correlated with significantly shorter overall survival and leukemia-free survival. Higher miR-124a expression also tended to be related to shorter survivals. Conclusions: Although our study was limited by the relatively small number of patients included, we identified several miRNAs associated with pathogenesis, leukemic transformation, and prognosis in MDS.
引用
收藏
页码:390 / 400
页数:11
相关论文
共 50 条
  • [41] A prognostic score for patients with lower risk myelodysplastic syndrome
    Garcia-Manero, G.
    Shan, J.
    Faderl, S.
    Cortes, J.
    Ravandi, F.
    Borthakur, G.
    Wierda, W. G.
    Pierce, S.
    Estey, E.
    Liu, J.
    Huang, X.
    Kantarjian, H.
    LEUKEMIA, 2008, 22 (03) : 538 - 543
  • [42] Prognostic Significance of Reduced BCAS4 expression in Bone Marrow Cells of Patients with Myelodysplastic Syndromes
    Shiseki, Masayuki
    Ishii, Mayuko
    Ohwashi, Mari
    Yoshinaga, Kentaro
    Mori, Naoki
    Tanaka, Junji
    BLOOD, 2019, 134
  • [43] Evaluation of P53 protein expression in patients with Myelodysplastic Syndrome (MDS): Prognostic impact
    Cascardi, E.
    Napoli, A.
    Ingravallo, G.
    Specchia, G.
    Maiorano, E.
    Resta, L.
    VIRCHOWS ARCHIV, 2016, 469 : S111 - S112
  • [44] Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients
    Santamaria, Carlos
    Muntion, Sandra
    Roson, Beatriz
    Blanco, Belen
    Lopez-Villar, Olga
    Carrancio, Soraya
    Sanchez-Guijo, Fermin M.
    Diez-Campelo, Maria
    Alvarez-Fernandez, Stela
    Sarasquete, Maria E.
    de las Rivas, Javier
    Gonzalez, Marcos
    San Miguel, Jesus F.
    Consuelo del Canizo, Maria
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (08): : 1218 - 1224
  • [45] CYTOGENETIC ABNORMALITIES IN CHILDHOOD ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME AND PROGNOSTIC SIGNIFICANCE
    Baka, M.
    Servitzoglou, M.
    Divane, A.
    Pourtsidis, A.
    Bouhoutsou, D.
    Varvoutsi, M.
    Doganis, D.
    Dana, H.
    Panagopoulou, P.
    Kosmidis, H.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 236 - 236
  • [46] Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine
    Itzykson, R.
    Thepot, S.
    Eclache, V.
    Quesnel, B.
    Dreyfus, F.
    Beyne-Rauzy, O.
    Turlure, P.
    Vey, N.
    Recher, C.
    Boehrer, S.
    Gardin, C.
    Ades, L.
    Fenaux, P.
    LEUKEMIA, 2011, 25 (07) : 1207 - 1209
  • [47] Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine
    R Itzykson
    S Thépot
    V Eclache
    B Quesnel
    F Dreyfus
    O Beyne-Rauzy
    P Turlure
    N Vey
    C Recher
    S Boehrer
    C Gardin
    L Adès
    P Fenaux
    Leukemia, 2011, 25 : 1207 - 1209
  • [48] Platelet glycoprotein expression in patients with myelodysplastic syndrome
    Seidl, C
    Siehl, J
    Ganser, A
    Hofmann, WK
    Fischer, M
    Kirchmaier, CM
    Hoelzer, D
    Seifried, E
    THROMBOSIS RESEARCH, 2000, 100 (01) : 27 - 34
  • [49] Expression analysis and prognostic significance of the PHLPP gene in acute leukemias and myelodysplastic syndromes
    Ono, Takaaki
    Nakamura, Satoki
    Kazuyuki, Shigeno
    Takeshita, Kaori
    Keiji, Okinaka
    Hirano, Isao
    Fujisawa, Shinya
    Ohnishi, Kazunori
    BLOOD, 2007, 110 (11) : 126B - 126B
  • [50] Prognostic significance of hyperfibrinogenemia in patients with lower-risk myelodysplastic syndromes
    Shinji Ogura
    Shoichiro Yonei
    Tomohiko Tanigawa
    Masahiro Akimoto
    Aki Sakurai
    Yuriko Fujita
    Chisako Ito
    Yoshinobu Aisa
    Tomonori Nakazato
    Annals of Hematology, 2020, 99 : 189 - 191